ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134033 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134033; 2) Community: the network communities that were significantly associated with the response to NSC 134033; 3) Molecule: the relationships between components within communities and NSC 134033; 4) MDR: the compounds that were significantly associated with the NSC 134033.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.0480633950058475 -0.14715537
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.32968611
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0480633950058475 0.21286937
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0480633950058475 -0.090275416
NSC 732205 Null 0.0480633950058475 0.25043931
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0480633950058475 0.15884984
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 0.0036156785
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0480633950058475 0.27536127
NSC 750050 Null 0.0480633950058475 0.24470588
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0480633950058475 0.45712382
Total:115  Current:112    [First] [Prev] [Next] [Last]